{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Caris Life Sciences, Inc."},"Symbol":{"label":"Symbol","value":"CAI"},"Address":{"label":"Address","value":"750 W. JOHN CARPENTER FREEWAY,SUITE 800, IRVING, Texas, 75039, United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Medical Specialities"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Caris Life Sciences is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Our current commercial product portfolio is focused on oncology and consists of MI Profile, our tissue-based molecular profiling solution that has generated the majority of our revenue to date, and Caris Assure, our novel, universal blood-based molecular profiling solution that was broadly launched in the first quarter of 2024 for therapy selection."},"CompanyUrl":{"label":"Company Url","value":"www.carislifesciences.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}